Literature DB >> 23462054

MiRNA s in oesophageal squamous cancer.

Y Chu1, H Zhu, L Lv, Y Zhou, J Huo.   

Abstract

Oesophageal cancer is a common cancer worldwide with a very poor prognosis. Oesophageal squamous cell carcinoma (OSCC) is the major subtype of oesophageal cancer but also one of the least studied cancers worldwide. Although the molecular genetics of OSCC have been widely studied, the molecular mechanism of OSCC carcinogenesis is not completely understood. MicroRNA (miRNA) is now essential to understanding the molecular mechanism of cancer progression. Recent findings include the following: 1) recent findings regarding the functions of miRNA; 2) some of the latest findings on expression profile of miRNA involved in OSCC; 3) miRNAs and their target genes and molecular mechanisms in OSCC; and 4) the therapeutic-clinical potential of miRNAs in OSCC. We can make full use of this knowledge to guide us to evaluate and improve the patient's condition and choose the most fitting medical treatment or explore new approaches to improve the survival ratio of OSCC patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462054

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  10 in total

1.  miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway.

Authors:  Haidong Xu; Xiaozhou Liu; Juan Zhou; Xiaoyun Chen; Jianning Zhao
Journal:  Oncol Lett       Date:  2016-11-07       Impact factor: 2.967

2.  Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway.

Authors:  Haoying Yang; Jun Zhang; Jiuping Li; Furong Zhao; Yao Shen; Xuemei Xing
Journal:  Exp Ther Med       Date:  2018-09-05       Impact factor: 2.447

3.  MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value.

Authors:  Xuejiao Wu; Jia Huang; Zilin Yang; Ying Zhu; Yongping Zhang; Jiancheng Wang; Weiyan Yao
Journal:  Cancer Cell Int       Date:  2020-09-10       Impact factor: 5.722

Review 4.  Small non-coding RNA and colorectal cancer.

Authors:  Hui Chen; Zhiying Xu; Deliang Liu
Journal:  J Cell Mol Med       Date:  2019-02-23       Impact factor: 5.310

5.  MicroRNA-550a is associated with muscle system conferring poorer survival for esophageal cancer.

Authors:  Housong Hong; Taisheng Liu; Huazhen Wu; Jinye Zhang; Xiaoshun Shi; Xiaobing Le; Allen M Chen; Haiyun Mo; Qianqian Huang; Huaping Zhou; Xuguang Rao
Journal:  Biosci Rep       Date:  2019-05-31       Impact factor: 3.840

6.  circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.

Authors:  Jun Wan; Yupeng Liu; Feng Long; Jian Tian; Can Zhang
Journal:  Cancer Sci       Date:  2021-03-10       Impact factor: 6.716

Review 7.  Molecular Landscape of Small Bowel Adenocarcinoma.

Authors:  Karan Pandya; Michael J Overman; Pat Gulhati
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.639

8.  A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.

Authors:  Heath D Skinner; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; Wayne Hofstetter; Ritsuko Komaki; Hironori Shiozaki; Roopma Wadhwa; Kazuki Sudo; Elena Elimova; Shumei Song; Yuanqing Ye; Maosheng Huang; Jaffer Ajani; Xifeng Wu
Journal:  Cancer       Date:  2014-08-04       Impact factor: 6.860

Review 9.  Pleiotropic functions of miR107 in cancer networks.

Authors:  Zhiying Luo; Yi Zheng; Wei Zhang
Journal:  Onco Targets Ther       Date:  2018-07-18       Impact factor: 4.147

Review 10.  Functional implications of Rab27 GTPases in Cancer.

Authors:  Zhihong Li; Rui Fang; Jia Fang; Shasha He; Tang Liu
Journal:  Cell Commun Signal       Date:  2018-08-06       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.